Tumor Ablation Industry Overview

The global tumor ablation market size is anticipated to reach USD 4.0 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 13.5% from 2024 to 2030. An increasing incidence of cancer and high demand for effective treatment options are the major factors contributing to market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020, and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported. The growing preference for minimally invasive procedures, attributed to advantages like fast recovery, patient comfort, and shorter turnaround times, is projected to drive demand for advanced tumor ablation techniques.

Gather more insights about the market drivers, restrains and growth of the Tumor Ablation Market

Furthermore, the integration of such devices with highly effective interventional imaging technologies, such as ultrasound, MRI, and CT, is poised to bring about a transformation in ablation procedures conducted in outpatient settings. This shift is anticipated to substantially reduce costs for patients, including expenses related to hospital stays. Government-sponsored initiatives, including screening programs, awareness campaigns, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) in England initiated lung cancer screening programs in selected regions. Such initiatives are expected to increase the demand for early-stage cancer management, thus driving market growth.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global biosimilar contract manufacturing market size was valued at USD 8.59 billion in 2023 and is expected to grow at a CAGR of 15.9% from 2024 to 2030.

• The global fill-finish pharmaceutical contract manufacturing market size was estimated at USD 17.95 billion in 2024 and is projected to grow at a CAGR of 8.3% from 2025 to 2030. 

Tumor Ablation Market Segmentation

Grand View Research has segmented the global tumor ablation market based on technology, treatment, application, and region:

Tumor Ablation Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• Irreversible Electroporation
• HIFU
• Other Ablation Technologies

Tumor Ablation Treatment Outlook (Revenue, USD Million, 2018 - 2030)

• Surgical Ablation
• Laparoscopic Ablation
• Percutaneous Ablation

Tumor Ablation Application Outlook (Revenue, USD Million, 2018 - 2030)

• Kidney Cancer
• Liver Cancer
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Other Cancers

Tumor Ablation Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

 Key Companies profiled:

• Medtronic plc.
• Boston Scientific Corporation
• Johnson & Johnson Service Inc. (Ethicon, Inc.)
• AngioDynamics
• Bioventus Inc. (Misonix Inc.)
• EDAP TMS
• Chongqing Haifu Medical Technology Co., Ltd.
• Mermaid Medical
• HealthTronics, Inc.
• H.S. Hospital Service S.p.A.

Order a free sample PDF of the Tumor Ablation Market Intelligence Study, published by Grand View Research.